Inventor · disambiguated record
Yasuhiro Furuichi
Also filed as: FURUICHI YASUHIRO
18 granted patents·7 pending applications·64 citations·filing 1985–2021
92Inventor score
Files withAGENE RES INST CO LTD6GENECARE RES INST CO LTD6TAKAGI MOTOKI4ROCHE VITAMINS INC3DSM NUTRITIONAL PRODUCTS INC1
Top patents by PatentIndex Score
25 records- 0184US8470798B2Cancer cell-specific apoptosis-inducing agents that target chromosome stabilization-associated genesTAKAGI MOTOKI·Filed 2012·Granted Jun 25, 2013·5 cites·10 claims
- 0283US8193332B2Cancer cell-specific apoptosis-inducing agents that target chromosome stabilization-associated genesTAKAGI MOTOKI·Filed 2005·Granted Jun 5, 2012·9 cites·5 claims
- 0379US6472513B1Human gene RecQ4 encoding helicaseAGENE RES INST CO LTD·Filed 2000·Granted Oct 29, 2002·8 cites·3 claims
- 0477US8314073B2Cancer-cell-specific cell proliferation inhibitorsTAKAGI MOTOKI·Filed 2005·Granted Nov 20, 2012·2 cites·5 claims
- 0570US8299044B2Apoptosis inducer for cancer cellTAKAGI MOTOKI·Filed 2009·Granted Oct 30, 2012·2 cites·3 claims
- 0670US6955906B2Biotin biosynthetic genes having biotin synthase activityDSM NUTRITIONAL PRODUCTS INC·Filed 2004·Granted Oct 18, 2005·2 cites·8 claims
- 0760US2004259147A1Gene causative of rothmund-thomson syndrome and gene productAGENE RES INST CO LTD·Filed 2004·Application pending·0 cites
- 0858US7329497B2Gene causative of Rothmund-Thomson syndrome and its gene productAGENE RES INST CO LTD·Filed 2006·Granted Feb 12, 2008·0 cites·6 claims
- 0958US7081522B2Gene causative of Rothmund-Thomson syndrome and gene productAGENE RES INST CO LTD·Filed 2000·Granted Jul 25, 2006·2 cites·1 claims
- 1058US6335435B1Human gene RecQ4 encoding helicaseAGENE RES INST CO LTD·Filed 1998·Granted Jan 1, 2002·13 cites·9 claims
- 1157US8703930B2Cancer cell-specific apoptosis-inducing agents that target chromosome stabilization-associated genesGENECARE RES INST CO LTD·Filed 2013·Granted Apr 22, 2014·0 cites·10 claims
- 1257US6723544B2Biotin biosynthetic genesROCHE VITAMINS INC·Filed 2001·Granted Apr 20, 2004·0 cites·12 claims
- 1356US2007243570A1Apoptosis Inducer for Cancer CellGENECARE RES INST CO LTD·Filed 2004·Application pending·0 cites
- 1456US2023323355A1Antiviral silencing rna molecules, chemically modified antiviral silencing rna molecules with enhanced cell penetrating abilities, pharmaceutical compositions comprising same and uses thereof for treatment of viral infectionsSOLSTAR PHARMA INC·Filed 2021·Application pending·0 cites
- 1556US2014179769A1Cancer-cell-specific cytostatic agentGENECARE RES INST CO LTD·Filed 2014·Application pending·0 cites
- 1654US8809296B2Apoptosis inducer for cancer cellGENECARE RES INST CO LTD·Filed 2012·Granted Aug 19, 2014·0 cites·1 claims
- 1752US6365388B1Biotin biosynthetic genesROCHE VITAMINS INC·Filed 2000·Granted Apr 2, 2002·0 cites·12 claims
- 1852US2013131331A1Cancer-cell-specific cytostatic agentGENECARE RES INST CO LTD·Filed 2012·Application pending·0 cites
- 1952US2006240470A1Gene causative of Rothmund-Thomson syndrome and gene productAGENE RES INST CO LTD·Filed 2006·Application pending·0 cites
- 2051US2011033858A1siRNA DETECTION METHODGENECARE RES INST CO LTD·Filed 2009·Application pending·0 cites
- 2146US6544736B1Method for synthesizing cDNA from mRNA sampleNIPPON GENE CO LTD·Filed 1998·Granted Apr 8, 2003·10 cites·21 claims
- 2245US4764460ARecombinant sigma NS proteinHOFFMANN LA ROCHE·Filed 1985·Granted Aug 16, 1988·8 cites·12 claims
- 2333US5972611AHybridization carrier and a process for preparing the sameJSR CORP·Filed 1997·Granted Oct 26, 1999·3 cites·21 claims
- 2431US6117669ABiotin biosynthetic genesROCHE VITAMINS INC·Filed 1997·Granted Sep 12, 2000·0 cites·8 claims
- 2528US10548990B2Modified siRNA and pharmaceutical compositionGENECARE RES INSTITUTE CO LTD·Filed 2016·Granted Feb 4, 2020·0 cites·11 claims
Join the waitlist — get patent alerts
Get an alert when Yasuhiro Furuichi files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →